CIK 0001101026
- Non-accelerated filer
- Smaller reporting company
Zivo Bioscience, Inc.
Sign in to watch- Ticker
- ZIVO
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870699977
- Phone
- +1 248-452-9866
- Business address
- 21 E. LONG LAKE ROAD, SUITE 100, BLOOMFIELD HILLS, MI, 48304
- Former names
- HEALTH ENHANCEMENT PRODUCTS INC, WESTERN GLORY HOLE INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 37,688 shares (grant or award)
- 4 Open-market buy Director bought 41,666 shares at $1.20 ($49,999)
- 4 Open-market buy Director bought 157,692 shares at $1.30 ($205,000)
- 4 Open-market buy Director bought 45,000 shares at $1.00 ($45,000)
- 4 Open-market buy 10% owner bought 40,000 shares at $4.99 ($199,600)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market buy Director bought 7,200 shares at an average $3.53 ($25,448)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 300 shares at $2.64 ($792)
- 4 Open-market buy President and CEO bought 57 shares at $2.50 ($143)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 12,000 shares at $3.00 ($36,000)
- 4/A Derivatives Options or other derivatives
Page 3 of 12 · 239 filings